GOP House Committee Calls Marijuana ‘Gateway Drug,’ Opposes Cannabis Banking Reform, Wants Stricter Regulations On Legal Weed
The House Republican Policy Committee announced its formal opposition to the Secure and Fair Enforcement (SAFE) Banking Act and the Cannabis Users’ Restoration of Eligibility (CURE) Act, denouncing both measures that seek to integrate the marijuana industry into the federal banking system and remove past cannabis use as a hindrance to federal employment and security clearances.
CURE seeks to remove cannabis-related protections for federal workers.
In the recent report, the advisory committee took a shot at Vice President Kamala Harris’s comments that cannabis brought “joy” when she was a 2020 presidential candidate. The committee argued cannabis is a “hazardous drug with short and long-term impacts,” citing high THC levels.
These complex issues involving political disagreement over the very essence of cannabis and broader views on how, when, where and why to legalize, reschedule or decriminalize it are constantly on the minds of stakeholders across the board in this dynamic industry.
That said, you can expect to hear from …